Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Hypercalcemia

1-methyl-3-isobutylxanthine has been researched along with Hypercalcemia in 2 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Hypercalcemia: Abnormally high level of calcium in the blood.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benítez-Verguizas, J1
Esbrit, P1
Firek, AF1
Carter, WB1
Heath, H1

Other Studies

2 other studies available for 1-methyl-3-isobutylxanthine and Hypercalcemia

ArticleYear
Proliferative effect of parathyroid hormone-related protein on the hypercalcemic Walker 256 carcinoma cell line.
    Biochemical and biophysical research communications, 1994, Feb-15, Volume: 198, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Animals; Antibodies; Bucladesine; Calcium; Carcinoma

1994
Cyclic adenosine 3',5'-monophosphate responses to parathyroid hormone, prostaglandin E2, and isoproterenol in dermal fibroblasts from patients with familial benign hypercalcemia.
    The Journal of clinical endocrinology and metabolism, 1991, Volume: 73, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Adult; Cell Line; Cyclic AMP; Dinoprostone; Female; Fibroblasts; Humans

1991